Literature DB >> 24637489

Construction of a mouse Aos1-Uba2 chimeric SUMO-E1 enzyme, mAU, and its expression in baculovirus-insect cells.

Tomofumi Nakayama1, Eri Yuasa1, Ayumi Kanemaru1, Masayuki Saito1, Hisato Saitoh2.   

Abstract

Small ubiquitin-related modifier (SUMO) is a highly conserved protein that is covalently attached to target proteins. This posttranslational modification, designated SUMOylation, is a major protein-conjugation-driven strategy designed to regulate structure and function of cellular proteins. SUMOylation consists of an enzymatic cascade involving the E1-activating enzyme and the E2-conjugating enzyme. The SUMO-E1 enzyme consists of two subunits, a heterodimer of activation of Smt3p 1 (Aos1) and ubiquitin activating enzyme 2 (Uba2), which resembles the N- and C-terminal halves of ubiquitin E1 (Uba1). Herein, we describe the rational design of a single polypeptide version of SUMO-E1, a chimera of mouse Aos1 and Uba2 subunits, termed mAU, in which the functional domains appear to be arranged in a fashion similar to Uba1. We also describe the construction of a mAU plasmid for expression in a baculovirus-insect cell system and present an in situ SUMOylation assay using the recombinant mAU. Our results showed that mAU has SUMO-E1 activity, thereby indicating that mAU can be expressed in baculovirus-insect cells and represents a suitable source of SUMO-E1.

Entities:  

Keywords:  E1 enzyme; baculovirus; chimera-fusion protein; posttranslational modification; protein expression; protein structure; small ubiquitin-related modifier (SUMO); ubiquitin

Mesh:

Substances:

Year:  2014        PMID: 24637489      PMCID: PMC4049905          DOI: 10.4161/bioe.27544

Source DB:  PubMed          Journal:  Bioengineered        ISSN: 2165-5979            Impact factor:   3.269


  30 in total

1.  A simple in situ cell-based sumoylation assay with potential application to drug screening.

Authors:  Miyuki Muramatsu; Junsuke Uwada; Naoyuki Matsumoto; Hisato Saitoh
Journal:  Biosci Biotechnol Biochem       Date:  2010-07-07       Impact factor: 2.043

2.  Crystal structure of a fragment of mouse ubiquitin-activating enzyme.

Authors:  Roman H Szczepanowski; Renata Filipek; Matthias Bochtler
Journal:  J Biol Chem       Date:  2005-03-16       Impact factor: 5.157

Review 3.  SUMO junction-what's your function? New insights through SUMO-interacting motifs.

Authors:  Oliver Kerscher
Journal:  EMBO Rep       Date:  2007-06       Impact factor: 8.807

Review 4.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

Review 5.  Protein interactions in the sumoylation cascade: lessons from X-ray structures.

Authors:  Zhongshu Tang; Christina M Hecker; Astrid Scheschonka; Heinrich Betz
Journal:  FEBS J       Date:  2008-05-17       Impact factor: 5.542

6.  In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.

Authors:  Noriko Saitoh; Yasuhiro Uchimura; Taro Tachibana; Satoko Sugahara; Hisato Saitoh; Mitsuyoshi Nakao
Journal:  Exp Cell Res       Date:  2006-05-01       Impact factor: 3.905

Review 7.  SUMO and its role in human diseases.

Authors:  Kevin D Sarge; Ok-Kyong Park-Sarge
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

8.  Structural analysis of Escherichia coli ThiF.

Authors:  David M Duda; Helen Walden; John Sfondouris; Brenda A Schulman
Journal:  J Mol Biol       Date:  2005-06-17       Impact factor: 5.469

Review 9.  Activating the ubiquitin family: UBA6 challenges the field.

Authors:  Marcus Groettrup; Christiane Pelzer; Gunter Schmidtke; Kay Hofmann
Journal:  Trends Biochem Sci       Date:  2008-03-18       Impact factor: 13.807

10.  Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging.

Authors:  Jianping Jin; Xue Li; Steven P Gygi; J Wade Harper
Journal:  Nature       Date:  2007-06-28       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.